Linc is a Swedish investment company focused on product-oriented Nordic life-science businesses, mainly pharmaceuticals and medical technology. It takes ownership stakes rather than operating clinics or labs itself, and builds a concentrated portfolio of listed and private holdings. Investors use Linc as a vehicle for exposure to Nordic healthcare innovation and medtech.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 0 | — | 211.1 | — |
| Q1 2025 | 5 | — | -996 | — |
| Q2 2025 | 0 | — | 350.8 | — |
| Q4 2025 | 0 | — | -108.2 | -151.2% |
| Q1 2026 | 1.4 | -72.4% | -176.9 | — |
| Q2 2026 | 0.3 | — | 258.1 | -26.4% |
All markets — KeepWinning global stock screener
Other companies on Stockholm: Meko AB (publ) (MEKO), Enity Holding AB (publ) (ENITY), Stenhus Fastigheter i Norden AB (publ) (SFAST), Heba Fastighets AB (publ) (HEBA B), BTS Group AB (publ) (BTS B), ShaMaran Petroleum Ltd. (SNM SDB)